Trials / Unknown
UnknownNCT01851746
A Study of Docetaxel and Lobaplatin Versus Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
A Study of Docetaxel and Lobaplatin vs. Docetaxel and Carboplatin Combination Regimen in Patients With Platinum-sensitive (>6 Months) Relapsed Ovarian Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Wuhan University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effectiveness and security of lobaplatin combined with docetaxel in treatment of the sensitive recurrent ovarian cancer.
Conditions
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2013-05-10
- Last updated
- 2013-05-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01851746. Inclusion in this directory is not an endorsement.